Argent Biopharma’s (RGT) flagship CannEpil cannabis drug is set to pivot into the veterinary market, just weeks after it signed away the commercial rights in exchange for debt relief.
Jersey’s medical cannabis industry turned a profit for the first time in 2025, posting revenues of £12m, almost £50m in cumulative investment, and exports of nearly seven tonnes.
Ananda Pharma, now the leading force in pharmaceutical cannabis research in the UK, has announced that the former Chief Operating Officer of GW Pharmaceuticals and Jazz Pharmaceuticals will join its team.
A groundbreaking achievement is flying under the radar. Epidiolex, the first FDA approved cannabis-derived drug developed by GW Pharmaceuticals, is on track to surpass $1 billion in annual revenue—a feat that puts it in the league of blockbuster drugs like Humira and Lipitor.
British American Tobacco [stock_market_widget type=”chart” template=”line” assets=”BATS.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Tobacco giant British American Tobacco (BAT) has announced the launch of a second investment fund as part of its corporate venture arm, Btomorrow Ventures (BTV).
UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major trials using its proprietary compounds.
As reported by Cannabis Health Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders, with a number of former GW Pharmaceutical bosses on board.
Germany’s passage of CanG continues to drive up stock prices Yesterday, the President of Bundesrat, Manuela Schwesig, signed Germany’s landmark CanG bill, meaning it is now all but certain to be brought into law on April 01.
Big pharma has so far been cautious of diving headfirst into the cannabis industry, despite the growing body of evidence surrounding its medical benefits.
